Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study assessed the safety and treatment effect of intravenous (IV) Remodulin as an add-on therapy in neonates with persistent pulmonary hypertension of the newborn (PPHN).
Epistemonikos ID: 33b798fcc0a297ef86791efaa28812303d6f6e0a
First added on: May 12, 2024